Medtech companies raised more than $738 million in Q2

Venture capital firms invested more than $738 million during the second quarter of 2018, $1 million less than the first quarter of this year, according to the MoneyTree Report from PricewaterhouseCoopers (PwC) and CB Insights. There was a total of 61 deals during Q2, an increase from the 48 that the industry saw during Q1.

8 crowdfunded health devices you need to know

Companies including 3M and Aura Medical are turning to the popular websites Kickstarter and Indiegogo to get their ideas crowdfunded by people who want them to come to life. The idea behind a crowdfunding website is that if you back the project and donate a certain amount of money, you’ll get something in return, oftentimes

Pages: 1 2 3 4 5 6 7 8 9

This bioprinter could screen bacterial infections in minutes

Stanford researchers are developing a bioprinter that, when paired with an advanced bacteria scanner, could speed up screening for bacteria infections. The bioprinter consists of acoustic pulses that shoot through blood samples of a patient. The pulses push individual blood droplets onto a piece of paper. Tens of millions are printed on the final print,

Medtronic warns on connectivity issue with Guardian Connect app

Medtronic (NYSE:MDT) this month issued a letter to physicians warning them of a potential connectivity issue with the Guardian Connect mobile app. The medtech giant warned that people using the Guardian Connect system to keep track of their blood sugar levels should update to the latest version of the mobile app as soon as possible. Get

Sterigenics expands in the U.K.

Sterigenics today announced plans to build a new facility in the Chesterfield/Derbyshire, U.K.’s Markham Vale North area as the company looks to expand its footprint in Europe. The 60,000 square-foot facility is expected to be completed by the fourth quarter of 2018, with plans to install a Nordion JS10000 gamma irradiator with a research loop,

National Guideline Clearinghouse to live on despite feds bowing out

The nonprofit that has run the recently shuttered National Guideline Clearinghouse (NGC) for 20 years plans to replace the website and run it privately. Funding to support the federal Agency for Healthcare Research and Quality’s (AHRQ) clinical practice guideline website ended on July 16. ECRI Institute, which developed and maintained NGC since its inception in

NextFlex awarding $12 million to fund flexible hybrid electronics projects

NextFlex, the San Jose, Calif.–based hybrid electronics manufacturing institute, today announced $12 million in funding for seven projects in areas ranging from healthcare to avionics to infrastructure monitoring. The funding is part of NextFlex’s Project Call 3.0 and includes $7 million in cost-share contributions from participants. The Project Call program overall has awarded more than

MassDevice co-founder Johnson to lead MassMEDIC

MassDevice co-founder Brian Johnson is set to depart from the publication he founded nearly 10 years ago and take over as president of the Massachusetts Medical Device Industry Council (MassMEDIC). Johnson will succeed Tom Sommer as president of the regional medical technology association. Sommer has served as MassMEDIC’s president since the group was founded in 1996.

3D-printed corneas could save millions’ vision

British scientists have 3D printed the first human corneas, yielding a potential fix to the worldwide shortage of corneas for implantation. The Newcastle University researchers created a bio-ink using stem cells from a healthy donor cornea mixed with alginate and collagen. They used a simple, low-cost 3D bio-printer to extrude the bio-ink in concentric circles to form the shape

This new material could eliminate motors and actuators in robots and medical devices

Researchers at the University of Hong Kong have developed a new material that eliminates the need for motors and actuators to be used in robots, medical devices, prosthetic muscles, exoskeletons and more. The new actuating material is made from nickel hydroxide-oxyhydroxides and is powered by visible light, electricity and other stimuli. The material actuation is

3D color X-rays could help diagnose cancer, heart disease and more

New Zealand scientists performed the first-ever 3D, color X-rays on a human, using technology that could improve medical diagnostics in oncology, cardiology, neurology and orthopedics. Based on traditional black-and-white X-ray technology, the scanner incorporates the Medipix3RX detector chip, a particle-tracking technology developed for the CERN Large Hadron Collider. It was developed by the Medipix3 Collaboration, which

Band-aid-like patch boosts fluorescence brightness in diagnostic tests

Researchers at Washington University in St. Louis have created a high-tech metal nanostructure patch that increases fluorescence intensity by 100 times in medical diagnostic tests. Fluorescence-based biosensing and bioimaging technologies have been used to detect and image different biological species. It is convenient to use, but they have poor sensitivity. For example, the fluorescent signal

Digital Surgery touts artificial intelligence for the operating room

Officials at Digital Surgery (London) boast that they have successfully demonstrated a real-time, dynamic artificial intelligence (AI) system designed for the operating room. The patented AI platform includes surgical procedure roadmaps that are meant to aid the surgical team in an OR. The goal is to reduce risk and make surgery safer. “This is a huge milestone for

Here are the top 5 medtech stories of mid-2018

A growing U.S. trade war with China and other countries casts a pall on medtech — and U.S. business in general — in mid-2018. The landscape of the medical device industry continues to evolve, though. There’s a major corporate spinout in the works, as well as a mega-merger that apparently was not to be. Read

Pages: 1 2 3 4 5 6

Who’s afraid of the big, bad PMAs?

PMAs at FDA are often a scary process for medical devices developers. But that doesn’t have to be the case, according to Michael Drues, a regulatory consultant based outside Boston who has worked with both medical device companies and FDA. There are many myths around premarket approval, such as the idea that PMAs always require